NCT02784652View on ClinicalTrials.gov

Efficacy of Radiotherapy in Combination With Zoledronic Acid in Bone Metastasis Patients With Gastrointestinal Tumors

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Bone MetastasisGastrointestinal Cancer
Interventions
DRUG

Zoledronic acid

Zoledronic acid: every 4 weeks, 6 times, 4.0 mg iv

RADIATION

Radiotherapy

Radiotherapy: 5 days/ week, 3 Gy \* 10-13 fractions or 4 Gy \* 5 fractions,

Trial Locations (1)

Unknown

Severance hospital, Seoul

All Listed Sponsors
lead

Severance Hospital

OTHER

NCT02784652 - Efficacy of Radiotherapy in Combination With Zoledronic Acid in Bone Metastasis Patients With Gastrointestinal Tumors | Biotech Hunter | Biotech Hunter